Fc-fusion technology beyond half-life extension-Review of potential immunomodulatory and anti-inflammatory effects of rFVIIIFc in haemophilia A

被引：0
|
作者：
Lacroix-Desmazes, Sebastien [1 ]
Horneff, Regina [2 ]
Casiano, Sandra [3 ]
Santagostino, Elena [2 ]
机构：
[1] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Paris, France
[2] Swedish Orphan Biovitrum AB Sobi, Stockholm, Sweden
[3] Sanofi Genzyme, Cambridge, MA USA
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
extended half-life treatment; Fc-fusion technology; rFVIIIFc;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-16 (115
引用
收藏
页码：30 / 31
页数：2
相关论文
共 3 条
  • [1] Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology
    Daventure, Victoria
    Bou-Jaoudeh, Melissa
    Hannachi, Emna
    Reyes-Ruiz, Alejandra
    Trecco, Amelia
    Delignat, Sandrine
    Lacroix-Desmazes, Sebastien
    Deligne, Claire
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2025, 55 (02)
  • [2] Facile and Efficient Chemoenzymatic Semisynthesis of Fc-Fusion Compounds for Half-Life Extension of Pharmaceutical Components
    Hirasawa, Shigeo
    Kitahara, Yoshiro
    Okamatsu, Yoriko
    Fujii, Tomohiro
    Nakayama, Akira
    Ueno, Satoko
    Ijichi, Chiori
    Futaki, Fumie
    Nakata, Kunio
    Taki, Masumi
    BIOCONJUGATE CHEMISTRY, 2019, 30 (09) : 2323 - 2331
  • [3] Comparing projected prophylactic consumption and effects of recombinant factor VIII Fc Fusion (rFVIIIFc) and shorter half-life FVIII products in haemophilia
    Krishnan, S.
    Miners, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 844 - 845
1